Latest News for: usfda
Edit
Zydus Lifesciences gets USFDA nod for generic blood disorder drug
The Times of India 15 Jan 2026
Edit
Bionpharma Inc. Receives USFDA Approval for Etravirine Tablets Developed in Collaboration with STEERLife
Canada Newswire 13 Jan 2026
today announced that Bionpharma has received Abbreviated New Drug Application (ANDA) approval from the United States Food and Drug Administration (USFDA) for its generic Etravirine tablets.
Edit
Alembic Pharmaceuticals gets USFDA tentative nod for generic cancer treatment drug
The Times of India 12 Jan 2026
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its ...
Edit
Granules gets USFDA nod for generic ADHD drug
Business Line 08 Jan 2026
The product, used to ...
Edit
Granules India gets USFDA tentative nod for generic ADHD treatment tablets
The Times of India 08 Jan 2026
.
Edit
Sun Pharma arm recalls over 17,000 units of antifungal shampoo in US: USFDA
The Times of India 25 Dec 2025
Edit
USFDA issues Form 483 with 5 observations to Aurobindo Pharma's Andhra unit
The Economic Times 18 Dec 2025
Aurobindo Pharma said the USFDA issued a Form 483 with ...
Edit
Piramal Pharma shares in focus after USFDA issues form 483 for Kentucky unit
The Times of India 12 Dec 2025
The company expects a voluntary action indicated classification ... .
Edit
Alembic Pharmaceuticals gets USFDA nod for generic eye infection treatment suspension
Business Line 11 Dec 2025
Edit
USFDA approves Alembic Pharmaceuticals’ generic eye infection treatment suspension
The Siasat Daily 11 Dec 2025
The approval granted by the US Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Loteprednol Etabonate and Tobramycin Ophthalmic Suspension of strength 0.5 per ...
Edit
USFDA issues Form 483 with 3 observations to Ipca's Tarapur plant
The Times of India 05 Dec 2025- 1
- 2
- Next page »
